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Abstract 
Background: Tetanus is an acute, often fatal, disease caused by an exotoxin produced by the bacterium Clostridium 
tetani. It is characterized by generalized rigidity and convulsive spasms of skeletal muscles. Tetanus remains a major 
public health problem in Ethiopia like other developed nations. The aim of the present study was to assess the clinical 
profile and outcome of tetanus patients in a referral hospital, Northwest Ethiopia.
Methods: This is a retrospective cross sectional study in which we collected, compiled and analyzed medical records 
of patients aged greater than 15 years who were admitted at Felege Hiwot Referral Hospital from Sep 2012 to Sep 
2015. Tetanus was diagnosed using clinical observations. Data were entered, cleared, and analyzed using SPSS statisti-
cal software package.
Results: Among 110 tetanus cases 84 (76.4 %) were males. Trauma was the most common antecedent cause. Most 
of the patients had no history of tetanus toxoid immunization. Aspiration pneumonia at 34.5 % and dysautonomia at 
11.8 % were found to be the most frequently observed complications. About 36 (32.7 %) patients were died due to 
tetanus and the most common immediate cause of death was respiratory failure at (83.3 %). Patients’ area of residence 
(p = 0.004), type of complications (p = 0.00) and severity of tetanus (p = 0.00) were found statistically associated with 
the type of treatment outcomes.
Conclusions: In the study, the case-fatality rate was found to be very high. Therefore, there is a need to universal 
tetanus immunization and health information dissemination.
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Background
Tetanus, an infective intoxication of the nervous system 
by Clostridium tetani, is an ancient disease which is asso-
ciated with a high mortality rate. Despite the widespread 
availability of a safe and effective vaccine against this dis-
ease, it remains a major health problem in developing 
countries, and also occurs in countries with good stand-
ard of medical practice (Anuradha 2006; Ogunrin 2009).
Transmission is primarily by contaminated wounds 
(apparent and inapparent). C. tetani spores are found 
in soil and in animal and human faeces (Abrutyn 2008). 
Tetanus is a neurological disorder, characterized by 
increased muscle tone and spasms. Characteristically, 
early spasms of the facial muscles (“lockjaw”) are fol-
lowed by spasm of the back muscles and sudden, general-
ized tonic seizures (Abrutyn2008; Ogunrin 2009).
The majority of the tetanus cases occur in the develop-
ing countries where it is associated with high mortality 
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ranging from 40 to 60  % due to the lack of effective 
immunization, poor treatment of injuries and decline in 
protective antibodies. The mortality rate is much lower 
in developed countries due to the availability of facili-
ties for intensive care, unlike in the developing coun-
tries (Anuradha 2006; Chukwubike and God Spower 
2009; Khaskheli et  al. 2013; Tadesse and Gebre-Selassi 
2009). The World Health Organization (WHO) global 
and regional immunization profile report, the number 
of reported all forms of tetanus cases by the year 2014 
in European region was found to be 67 but it was 2900 
in Africa (WHO 2015a, b). This is likely to be a huge 
understatement.
Tetanus is classically divided into four clinical types: 
generalized, localized, cephalic, and neonatal. These are 
valuable diagnostic and prognostic distinctions, but they 
reflect host factors and the site of inoculation rather than 
differences in toxin action. Clinical findings showed that 
there are three different forms of tetanus namely; local, 
cephalic and generalized tetanus (WHO 2015a, b, c). It 
typically presents with trismus, difficulty in swallowing 
and more ominously difficulty in breathing or opisthoto-
nus (Ogunrin 2009).
The diagnosis is entirely clinical and does not depend 
upon bacteriologic confirmation. The management of 
tetanus patients is too demanding, prolonged, and expen-
sive both in terms of materials and manpower. The goal 
of therapy to tetanus cases is to eliminate the source of 
toxin, neutralize unbound toxin, and prevent muscle 
spasms while monitoring the patient’s condition and 
providing support, especially respiratory support until 
recovery (Ogunrin 2009; CDC 2015; WHO 2015a, c).
In Ethiopia, the prevalence and incidence of tetanus 
and its associated complications, control of the disease is 
far from adequate. Therefore, the aim of this study was 
to assess the demographic and clinical profile of tetanus 
patients at FHRH above the pediatric age group.
Methods
Study design, area, period and subjects
Medical records of tetanus patients were analyzed retro-
spectively to assess the demographic and clinical profile 
of 110 adult tetanus patients registered from 30 Sep 2012 
to 30 Sep 2015 in the department of internal medicine at 
FHRH, which is one of the referral hospitals in Amhara 
Regional State, Bahir Dar-Ethiopia. All complete data 
registered during the study period were taken from hos-
pital records for analysis. Tetanus was diagnosed by clini-
cal observations.
Data collection and analysis
The data was collected by retrospective examination 
of patient records using data extraction sheet. Patient’s 
demographic and clinical data such as; age, sex resi-
dence, TT immunization status, antecedent cause of 
tetanus, severity, complications, and outcome of teta-
nus were extracted for analysis. All data were entered, 
cleared, and analyzed using SPSS version 20 (IBM Corp. 
Released 2011. IBM SPSS Statistics for Windows, Version 
20.0. Armonk, NY: IBM Corp.). Descriptive statistics was 
used to present data and Chi square test was employed to 
assess association between tetanus treatment outcomes 
with relevant variables. Level of statistical significance 
was set at p value less than 0.05.
Ethical issue
Institutional ethical permission was obtained from the 
Research and Publication Committee Ethical Review 
Board of Bahir Dar University.
Results
Demographic data
Of the total registered tetanus patients 84 (76.4  %) 
were males. The mean age of the patients was 
43.4  ±  15.1  years. Of the registered study subjects, 66 
(60 %) of them were from rural areas. Among the study 
subjects, 17 (15.5 %) of the patients had prior TT immu-
nization history, while the majority of them, 93 (84.5 %) 
did not know their immunization status. Trauma at 66 
(60 %) of the cases was the most common causes of teta-
nus. Forty (36.4 %) patients arrived to the hospital with 
in 72 h after the antecedent cause. Out of the 84 tetanus 
patients 9 (10.7  %) took TAT prophylaxis (Table  1). Of 
these nine patients, 5 (55.6 %) of them had severe form 
of tetanus and 2 (22.2  %) of them died in the course of 
their management as compared with those patients who 
didn’t take TAT who end up with severe form of tetanus, 
21 (53.8 %) and death, 15 (38.5 %).TAT prophylaxis didn’t 
show statistical significance with severity and outcome of 
tetanus (p > 0.05).
Clinical profile of tetanus patients
Among the study subjects, 103 (93.6 %) were diagnosed 
with generalized tetanus during the time of admission. 
According to Ablett classification of severity of tetanus 
(Ogunrin 2009), overall 24 (21.8 %), 31 (28.2 %) and 55 
(50  %) patients were presented with mild, moderate 
and severe form of tetanus respectively. All patients 
diagnosed with tetanus have got the standard man-
agement protocol (TAT, muscle relaxant, antibiotics, 
put on dark room). Furthermore, 13 (11.8 %) patients’ 
received debridement procedure and a patient was 
transferred to intensive care unit (ICU) and was 
mechanically ventilated by intubation (oropharyngeal). 
Some of the study subjects encountered complica-
tions following tetanus. Aspiration pneumonia, at 36 
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(34.5  %) and autonomic dysfunction (dysautonomia) 
at 13 (11.8 %) were the most frequently observed com-
plications followed by upper airway obstruction at 6 
(5.5 %).
Of all managed patients, 36 (32.7 %) died, 37 (33.6 %) 
survival to hospital discharge, 37 (33.6  %) patients dis-
charged themselves against medical advice for unspeci-
fied reason. Most of the patients (80.6  %) died within 
1  week during their stay in the hospital indicating that 
patients did not get adequate respiratory support. The 
two most common cause of death were respiratory failure 
at (83.3 %) and multi organ failure at (16.7 %) (Table 2). 
Management outcome of tetanus patients showed signifi-
cant statistical association with patients area of residence 
(p = 0.004), type of complications (p = 0.000) and sever-
ity of tetanus (p = 0.000) (Table 3).  
Discussion
Regardless of efforts made by the WHO, tetanus remains 
a global health problem. Lack of immunization, low 
level of education, poor wound management and per-
sonal hygiene increased the burden of tetanus in devel-
oping countries (Oladiran et  al. 2002). In addition, high 
incidence of tetanus admissions in developing countries 
has been attributed to low levels of health awareness in 
terms of vaccination and availability of human and mate-
rial resources to manage the disease (Amare et al. 2012). 
Researchers showed that mortality due to tetanus could 
be reduced intensified immunization efforts by all health 
care providers in the developing nations (Oladiran et al. 
2002; Woldeamanuel 2012).
Table 1 Demographic and  related clinical data of  tetanus 




 Male 84 (76.4) M:F ration 3.2:1
 Female 26 (23.6)
Age category
 15–25 15 (13.6) Mean: 43.4 years
SD: ±15.1
 26–35 22 (20.0)
 36–45 31 (28.2)
 46–55 14 (12.7)
 56–65 20 (18.2)
 >65 8 (7.3)
Residence
 Rural 66 (60)
 Urban 44 (40)
TT vaccination history
 Yes 17 (15.5)
 No 16 (14.5)
 Unknown 77 (70.0)
Antecedent causes
 Trauma 66 (60.0)
 Burn 3 (2.7)
 Surgery 3 (2.7)
 Devitalized tissue 5 (4.5)
 Co infection 4 (3.6)
 Cryptogenic 24 (21.8)
 Traditional practice 5 (4.5)
TAT prophylaxis given
 Yes 9 (10.7)
 No 39 (46.4)
 Unknown 36 (42.9)
Table 2 Clinical profile of  tetanus patients attended 
at FHRH, Bahir Dar, 2015
MOF multi organ failure
Variables Frequency (%)
Clinical presentation
 Local 3 (2.7)
 Cephalic 4 (3.6)
 Generalized 103 (93.6)
Onset of symptoms after injury
 <3 days 40 (36.4)
 3–14 days 35 (31.8)
 >14 days 13 (11.8)
 Unknown 22 (20.0)
Managements given
 Standard Mgt 110 (100)
 Debridement 13 (11.8)
 Oropharyngeal intubation 1 (0.9)
Complications
 Aspiration pneumonia 38 (34.5)
 Autonomic dysfunction 13 (11.8)
 Air way obstruction 6 (5.5)
 Renal failure 2 (1.8)
 Decubitus ulcer 2 (1.8)
 None 49 (44.6)
Severity
 Mild 24 (21.8)
 Moderate 31 (28.2)
 Severe 55 (50.0)
Management outcome
 Death 36 (32.7)
 Survival to hospital discharge 37 (33.6)
 Against medical advice 37 (33.6)
Causes of death
 Respiratory failure 30 (83.33)
 MOF 6 (16.67)
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The burden of tetanus is high only in resource limited 
countries like Ethiopia. Agrarian rural life with limited 
vaccine typifies tetanus risk in Ethiopia (Woldeamanuel 
2012). At present, the country is involved in expanding 
tetanus control trends through infant immunization and 
eliminating highly prevalent maternal and neonatal teta-
nus (MNT) (Woldeamanuel 2012).
High incidence of tetanus admissions in develop-
ing countries like Ethiopia is attributed to low levels of 
health awareness in terms of vaccination and availability 
of human and material resources to manage the disease 
(Amare et al. 2012; Woldeamanuel 2012).
In this study majority of the tetanus patients were 
males and rural dwellers. Similarly, the most common 
portal of entry among patients in this study was trauma, 
which constituted 60  % of all the admitted tetanus 
patients. Similar finding was reported by a study from 
India (Anuradha 2006).
In the present study, 84.5 % of the tetanus patients had 
no prior tetanus immunization. This might be due to low 
coverage of tetanus vaccination in the study area. Fur-
thermore the finding showed that 10.7 % of the patients 
took TAT prophylaxis. The immunization status of adults 
in the third world countries like Ethiopia is quite limited. 
The primary immunization, including maternal immu-
nization coverage and addressing the recommended 
booster dose for candidates is inadequate (Amare et  al. 
2012).
In the present study, 21.8, 28.2 and 50 % of the tetanus 
patients had mild, moderate and severe form of tetanus 
during the time of presentation respectively. Compara-
ble finding was reported by other studies (An et al. 2015; 
Tadesse and Gebre-Selassi 2009). Aspiration pneumo-
nia at 34.5 % and dysautonomia at 11.8 % were the most 
frequently observed complications in our study. These 
results are consistent with others (Amare et  al. 2012; 
Anuradha 2006). Researchers showed that the use of 
intensive treatment for tetanus patients decreased the 
incidence of respiratory complications (Chukwubike and 
God Spower 2009; Oshinaike et  al. 2012; Tadesse and 
Gebre-Selassi 2009). Prior to the introduction of inten-
sive care unit (ICU) including ventilation, 80 % of deaths 
due to tetanus were related to acute respiratory failure 
(Oshinaike et al. 2012; Tadesse and Gebre-Selassi 2009).
In the present study, respiratory failure at 83.3  % was 
found to be one of the principal immediate causes of 
death, which is in agreement with other studies (Amare 
and Yami 2011; An et al. 2015; Tadesse and Gebre-Selassi 
2009). This might be due to availability of very limited 
ICU services in the country. In this study the reported 
mortality rate was at 32.7 %. Likewise, studies conducted 
elsewhere in Ethiopia reported the same trend ranging 
from 27 to 41.7  % (Amare et  al. 2012; Amare and Yami 
Table 3 Tetanus management outcome of  study subjects 
at FHRH, Bahir Dar, 2015









 Male 29 27 28 84 0.742
 Female 7 10 9 26
Residence
 Urban 14 22 8 44 0.004
 Rural 22 15 29 66
TT vaccination history
 Yes 4 8 5 17 0.428
 No 4 4 8 16
 Unknown 28 25 24 77
TAT prophylaxis history
 Yes 2 4 3 9 0.856
 No 15 12 12 39
 Unknown 11 14 11 36
 Not required 8 7 11 26
Antecedent cause of tetanus
 Trauma 20 25 21 66 0.094
 Burn 2 1 0 3
 Surgery 0 1 2 3
 Devitalized tissue 3 1 1 5
 Co infection 0 4 0 4
 Cryptogenic 10 4 10 24
 Traditional  
practice
1 1 3 5
Clinical presentation
 Local 2 1 0 3 0.217
 Cephalic 1 3 0 4
 Generalized 33 33 37 103
Time gap between accident and presentation to the hospital
 <3 days 9 19 12 40 0.203
 3–14 days 12 12 11 35
 >14 days 5 3 5 13
 Unknown 10 3 9 22
Complications
 Aspiration  
pneumonia
22 5 11 38 0.000
 Autonomic  
dysfunction
2 6 5 13
 Air way  
obstruction
6 0 0 6
 Renal failure 2 0 0 2
 Decubitus ulcer 0 1 1 2
 No complications 4 25 30 59
Severity of tetanus
 Mild 1 23 0 24 0.000
 Moderate 5 12 14 31
 Severe 30 2 23 55
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2011; Hodes and Teferedegne 1990; Tadesse and Gebre-
Selassi 2009). Furthermore, comparable findings were 
reported in Nigeria ranging from 42.9 to 56.2 % (Chuk-
wubike and God Spower 2009; Oladiran et al. 2002) and 
India at 37.8  % (Anuradha 2006). In contrast relatively 
low fatality rate at 6.4  % was reported in Vietnam (An 
et al. 2015), may be due to large scale availability of safe 
and effective vaccine in this country.
About 37 (33.6  %) patients discharged themselves 
against medical advice for unspecified reason. These 
patients might be less likely to survive and this obviously 
would imply that the outcome of tetanus could be worse 
than reported in this paper.
The main limitations of our study were, the study lacks 
detailed clinical data and analysis to identify predictors of 
mortality. This calls for the improvement in documenta-
tion and keeping of medical records of patients properly. 
However, our study is one of the few that provides baseline 
information concerning Tetanus patients at FHRH, north-
west Ethiopia, and this could be useful for planning appro-
priate Tetanus control strategies, especially in the present 
study areas and in settings where Tetanus is common.
Conclusions and recommendations
In conclusion, high case fatality rate at 33  % was docu-
mented due to tetanus in the studied area. Efforts to iden-
tify complications early in the course of the disease will 
help to recognize patients that will need more intensive 
treatment. Widespread use of appropriate vaccination 
and prophylaxis is essential to prevent tetanus. Conse-
quently, continuous and intensified public health strate-
gies on health education as well as universal and adequate 
coverage of immunization program are required.
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